Peter E. Jensen
No Rating Available
(Learn About Our Rating System)

Peter E. Jensen, MD

Languages spoken: English

Dr. Jensen is Chairman of the Department of Pathology in the School of Medicine and Chairman of the Board of Directors, ARUP Laboratories, University of Utah's national diagnostic reference laboratory. He received his M.D. from Vanderbilt University, followed by residency training in Anatomic Pathology and research training in immunology at Washington University. Dr. Jensen joined the faculty of the Department of Pathology and Laboratory Medicine at Emory University in 1986, where he ultimately served as Professor, Vice Chair, Director of the Experimental Pathology Division, Medical Director of the Clinical Immunology Laboratory at Emory University Hospital, and Director of the interdepartmental graduate program in Immunology and Molecular Pathogenesis. He has broad interests in health care transformation, precision diagnostics, and the application of new technology in pathology and laboratory medicine. Dr. Jensen joined the University of Utah in 2004.

Specialties

  • Pathology

Board Certification

American Board of Pathology (Sub: Anatomic Path)

Dr. Jensen is Chairman of the Department of Pathology in the School of Medicine and Chairman of the Board of Directors, ARUP Laboratories, University of Utah's national diagnostic reference laboratory. He received his M.D. from Vanderbilt University, followed by residency training in Anatomic Pathology and research training in immunology at Washington University. Dr. Jensen joined the faculty of the Department of Pathology and Laboratory Medicine at Emory University in 1986, where he ultimately served as Professor, Vice Chair, Director of the Experimental Pathology Division, Medical Director of the Clinical Immunology Laboratory at Emory University Hospital, and Director of the interdepartmental graduate program in Immunology and Molecular Pathogenesis. He has broad interests in health care transformation, precision diagnostics, and the application of new technology in pathology and laboratory medicine. Dr. Jensen joined the University of Utah in 2004.

Board Certification and Academic Information

Academic Departments Pathology -Professor
Board Certification
American Board of Pathology (Sub: Anatomic Path)

Education history

Undergraduate Chemistry - Bates College
Undergraduate Biochemistry - University of Georgia B.S.
Professional Medical Medicine - Vanderbilt University M.D.
Internship Pathology - Barnes-Jewish Hospital Intern
Residency Pathology - Barnes-Jewish Hospital Resident

Selected Publications

Journal Article

  1. LI Q, Shakya A, Guo X, Zhang H, Tantin D, Jensen PE, Chen (2012). Constitutive nuclear localization of NAT in Foxp3+ regulatory T cells independent of calcineurin activity. Journal of immunology (Baltimore, Md., 188, 4268-4277.
  2. Chen L, Jay Dc, Fairbanks JD, He X, Jensen P (2011). An MHC class 1b-restricted CD8+T cell response to lymphocytic choriomeningitis virus. Journal of immunology (Baltimore, Md., 187, 6463-6472.
  3. Escobar H, Reyes-Vargas E, Jensen PE, Delgado JC, Crockett, D (2011). Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides. Journal of proteome research, 10, 2494-2507.
  4. Delgado JC, Escobar H, Crockett DK, Reyes-Vargas E, Jensen P (2009). Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics predication. Immunogenetics, 61, 241-246.
  5. Chen LC, Delgado JC, Jensen PE, Chen (2009). Direct expansion of human allospecific Fox P3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. Journal of immunology (Baltimore, Md., 183, 4094-4102.
  6. Zhou Z, Callaway KA, Weber DA, Jensen P (2009). Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. Journal of immunology (Baltimore, Md., 183, 4187-4191.
  7. Chen X, Jensen P (2008). The role of B lymphocytes as antigen-presenting cells. Archivum immunologiae et therapiae experimentalis, 56, 77-83.
  8. Chen X, Jensen P (2008). MHC clsss IIantigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes. Experimental and molecular pathology, 85, 40-44.
  9. Delgado JC, Jensen P (2008). Cat and mouse. Nature immunology, 9, 829-830.